#62025TJ0476EU Court Judgment on Likelihood of Confusion in Trademark Case
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
🇬🇧 English
The General Court ruled there is no likelihood of confusion between the EU trademark application for 'Serosan' and the existing Spanish mark 'Clenosan'. Both companies operate in health-related products, but the court found the visual and phonetic differences sufficient to avoid confusion. Ionfarma's opposition to the trademark application was dismissed, impacting the parties involved in EU trademark opposition proceedings.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Court rules no likelihood of confusion between 'Serosan' and 'Clenosan'.
- Visual and phonetic differences deemed sufficient to differentiate marks.
- Iofarma's trademark opposition dismissed by the General Court.
Affected Parties
Iofarma, SLVision Healthcare BV
Tags
trademark,intellectual property,court decision